Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Natco Pharma has launched Hepatitis C drug in Nepal

On Wednesday, Natco Pharma said that in Nepal, it has launched generic Hepcinat LP which is in the treatment of chronic hepatitis C infection in adults.

The company said in a filing to BSE that NATCO priced its generic medicine, Hepcinat LP, at Rs 25,000 for a bottle of 28 tablets in Nepal.

Hepcinat LP is used in the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults and is a generic version of Ledipasvir and Sofosbuvir combination.

Read EquityPandit’s Technical Analysis On CNX Pharma

Get Daily Prediction & Stocks Tips On Your Mobile